logo

For the Inventor, By the Inventor

Fontanella, Italy

Carla Bonetti

USPTO Granted Patents = 14

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 48(Granted Patents)


Location History:

  • Bergamo, IT (1993)
  • Fontanella, IT (1990 - 1996)

Company Filing History:

goldMedal14 out of 854 
 
Roussel Uclaf
 patents

Years Active: 1990-1996

Loading Chart...
14 patents (USPTO):Explore Patents
1. 5532375 - Process for preparing 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oximes (1996-07-02),
2. 5391754 - Process for preparing 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime (1995-02-21),
3. 5231107 - Derivatives of the oxime of 1,2,5,6-tetrahydropyridine 3-carboxaldehyde, (1993-07-27),
4. 5219873 - Compounds of 1,2,5,6-tetrahydropyridine which are useful as cholinergic (1993-06-15),
5. 5219872 - Compounds of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime which are (1993-06-15),
6. 5204479 - Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime (1993-04-20),
7. 5204341 - 1-arylsulphonyl-2-pyrrolidone derivatives, their preparation process and (1993-04-20),
8. 5183896 - Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime (1993-02-02),
9. 5183893 - 1-azabicycloalkane derivatives, their preparation process and their use (1993-02-02),
10. 5053416 - Derivatives of 1,2,5,6-tetrahydropyridine substituted by a thiazolyl or (1991-10-01),
11. 5015655 - 1-azabicycloalkane derivatives, their preparation process and their use (1991-05-14),
12. 4927837 - Derivatives of 3-piperidine carbaldehyde oxime and their use as (1990-05-22),
13. 4921868 - Carbamate derivatives of the oxime of (1990-05-01),
14. 4902699 - Oxime of 1, 2, 5, 6-tetrahydropyridine compounds their use as (1990-02-20),

Title: Carla Bonetti: Innovator in Alzheimer's Disease Treatments

Introduction: Carla Bonetti is a notable inventor based in Fontanella, Italy, recognized for her significant contributions to the field of pharmaceutical innovations. With a total of 14 patents to her name, she has been dedicated to developing compounds that hold promise in the treatment of Alzheimer's disease, senile dementia, and other memory disorders.

Latest Patents: Among her recent innovations, Carla Bonetti has developed a process for preparing 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oximes. This compound is particularly valuable for its potential therapeutic applications in treating Alzheimer's disease and other cognitive memory disorders. The compounds possess a chemical formula that includes a variety of alkyl radicals and their addition salts with acids, which enhances their applicability in medicinal chemistry.

Career Highlights: Carla works at Roussel Uclaf, a well-regarded organization that focuses on health and pharmaceutical innovations. Her career is marked by a passion for advancing research in the treatment of debilitating neurodegenerative diseases. The impact of her patents is expected to drive significant advancements in the pharmaceutical industry, particularly within the realm of cognitive health.

Collaborations: Throughout her career, Carla has collaborated with esteemed colleagues such as Emilio Toja and Giulio Galliani, whose combined expertise enriches the research environment. These collaborations are vital for fostering innovative ideas and translating scientific research into practical applications that can improve patient outcomes.

Conclusion: Carla Bonetti exemplifies the role of a dedicated inventor committed to addressing critical health challenges. Her innovative patents and collaborative spirit showcase her as a key figure in the fight against Alzheimer’s and memory-related disorders. As research in this area continues to evolve, the contributions of inventors like Carla will undoubtedly lead to meaningful advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…